Current Report Filing (8-k)
November 09 2017 - 7:31AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
November
9, 2017
Date
of Report (Date of earliest event reported)
CHARLES RIVER
LABORATORIES
INTERNATIONAL,
INC.
(Exact
Name of Registrant as Specified in Charter)
Delaware
|
001-15943
|
06-1397316
|
(State or Other
Jurisdiction of Incorporation)
|
(Commission File Number)
|
(IRS Employer
Identification No.)
|
251 Ballardvale Street
Wilmington, Massachusetts 01887
|
(Address
of Principal Executive Offices) (Zip Code)
|
781-222-6000
(
Registrant’s
Telephone Number, including Area Code)
Check the
appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
⃞
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
⃞
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
⃞
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
⃞
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (17 CFR
§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR
§240.12b-2).
Emerging growth company
⃞
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with
any new or revised financial accounting standards provided pursuant to
Section 13(a) of the Exchange Act.
⃞
ITEM 2.02. Results of Operations and Financial Condition
The following information shall not be deemed "filed" for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the
"Exchange Act"), or incorporated by reference in any filing under the
Securities Act of 1933, as amended, or the Exchange Act, except as shall
be expressly set forth by specific reference in such a filing.
On November 9, 2017, Charles River Laboratories International, Inc.
issued a press release providing financial results for the quarter ended
September 30, 2017.
The press release, attached as an exhibit to this report, includes "safe
harbor" language pursuant to the Private Securities Litigation Reform
Act of 1995, as amended, indicating that certain statements contained in
the press release are "forward-looking" rather than historic. The press
release also states that these and other risks relating to Charles River
are set forth in the documents filed by Charles River with the
Securities and Exchange Commission.
ITEM 9.01. Financial Statements and Exhibits
(a) Not applicable.
(b) Not applicable.
(c) Exhibits.
99.1 Press release dated November 9, 2017.
SIGNATURES
Pursuant to
the requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
|
|
CHARLES RIVER LABORATORIES
INTERNATIONAL, INC.
|
|
|
|
|
Date:
|
November 9, 2017
|
By:
|
/s/ Matthew L. Daniel
|
|
|
|
Matthew L. Daniel, Corporate Senior Vice President,
|
|
|
|
Legal Compliance, Deputy General Counsel and Assistant
Secretary
|
EXHIBIT INDEX
4
Charles River Laboratories (NYSE:CRL)
Historical Stock Chart
From Aug 2024 to Sep 2024
Charles River Laboratories (NYSE:CRL)
Historical Stock Chart
From Sep 2023 to Sep 2024